Book Value per Share: CareDx Health (CDNA)

Graphic logo of caredx.com (CDNA)

CareDx, Inc (CDNA) possesses undeniable influence in the field of transplant monitoring, having earned the trust of medical professionals through the flawless accuracy of its diagnostic systems. Process continuity is guaranteed by the prompt delivery of biomaterials via a network of verified couriers. The available price action vector, where the indicator stands at 8.24, complements the picture of a business that integrates IT services and tests for the lifelong management of organ recipients.

CareDx (CDNA) - Accounting Value per Share from 07/04/2022 to 10/27/2026

Summary analytical data breakdowns for CareDx Health (CDNA)

- price and consensus price forecast:
Price Chart CareDx Inc|CDNA - Broker Consensus Forecast
- market capitalization data:
Market Capitalization CareDx, Inc.|CDNA - Enterprise Value
- book capitalization data:
Net Assets per Single Share CareDx|CDNA - Company Net Assets|Market Capitalization to Book Value Ratio caredx.com|CDNA - Company Assets
- debt and liquidity data:
Total Debt to Capital CareDx, Inc|CDNA - Long-Term Debt to Capital Ratio|Short-Term Debt to Capital CareDx, Inc|CDNA - Company Aggregate Debts|Debt to Book Capitalization Ratio CareDx, Inc.
Fundamental company valuation:CareDx, Inc
Manufactured product of CareDx Health

Book value per share reflects the net value of a company's capital after all liabilities are settled. This metric is calculated by dividing total equity by the number of outstanding shares. The book value per share trend allows for the identification of the gap between market hype and the actual asset base. For CareDx, Inc (CDNA), this foundation is bolstered by its status as a leader in non-invasive transplant monitoring. High physician confidence translates into the stability of the company's material base.

Competitors of CareDx, Inc (CDNA)

Agilent Tech (A) - Net Assets per Single Share|DGX - Equity per Share|ILMN: Book Value per Share|EXAS (exactsciences.com) - Book Value per Share|Net Assets per Single Share RVTY|Accounting Value per Share Bio-Rad Laboratories, Inc.|Anbio Tech - Book Value per Share|Net Asset Value per Share Nordion (SHC)|QDEL - Book Value per Share|Equity per Share opko.com OPK|Maravai LifeSciences Holdings, Inc. - Book Value per Share|FLGT: Book Value per Share|Net Assets per Single Share Fluidigm|Cytek Corp (CTKB) - Equity per Share|OSUR (OraSure Technologies) - Book Value per Share|Book Value per Share XGN|Net Assets per Single Share MDxHealth (MDXH)|Net Assets per Single Share Lucid Diagnostics, Inc. LUCD|PRE: Accounting Value per Share|Insight Molecular Diagnostics, Inc. - Net Asset Value per Share|Net Assets per Single Share TRIB (Trinity Biotech Corp)|PRPH - Net Assets per Share|Ainos - Book Value per Share|CODX (Co-Diagnostics Inc) - Net Assets per Share|HSCS: Net Assets per Single Share|Net Assets per Share Biomerica Inc|Book Value per Share CDIO (Cardio Diagnostics)|Accounting Value per Share viraxbiolabs.com (VRAX)|Book Value per Share BJDX (Bluejay Diagnostics, Inc.)|Aspira Women's Health, Inc. - Book Value per Share|Net Assets per Single Share Accelerate Diagnostics, Inc (AXDX)|CNTG - Accounting Value of a Share|Book Value per Share ENZ|Fresh2 Group (FRES) - Net Asset Value per Share|Book Value per Share Genetic Technologies Ltd (GENE)|Equity per Share 23andMe Holding Co (ME)|Accounting Value per Share Psychemedics Corp PMD